Effect of COVID-19 booster vaccination on reducing mortality of patients hospitalized for COVID-19 at Sisaket Hospital
Keywords:
Booster shot, Covid-19 vaccine, hospital mortalityAbstract
Background: Coronavirus disease 2019 (COVID-19) vaccines have the potential to decrease hospitalizations and mortality, regardless of the vaccine type. Toward the end of 2021, with the COVID-19 pandemic still ongoing, guidelines suggest the administration of booster shots once the primary vaccination series is completed.
Objective:This study aimed to investigate the efficacy of COVID-19 booster vaccinations and the timing between booster shots in terms of preventing mortality among patients with COVID-19 hospitalized at Sisaket Hospital.
Methods: A retrospective cohort study was conducted on individuals aged 18 years who were hospitalized with COVID-19 at Sisaket Hospital between January 1, 2022, and December 31, 2022. Data analysis was performed using descriptive statistics and multiple regression analysis techniques.
Results: The study included a total of 1,853 patients (women = 1,050, (56.7%)). The average age was 53.8 ± 20.4 years. Among them, 330 (17.8%) patients expired. According to vaccination history, the survival rates for those who did not receive any vaccination, received an incomplete primary vaccination series, and completed the primary series were 68.5%, 75.9%, and 85.6%, respectively. The survival rates of the groups that received one and two booster shots were 88.6% and 96.2%, respectively. Regarding the time interval between receiving booster shots, statistically significant differences were found among those vaccinated within 3, 3-6, and > 6 months.
Conclusion: COVID-19 booster vaccination has proven its efficacy in preventing fatalities among patients hospitalized for COVID-19, even after a single booster shot. In addition, a booster shot received > 6 months can still reduce the mortality rates compared with booster shots administered within 3 months, without significant difference.
Downloads
References
Khan M, Adil SF, Alkhathlan HZ, Tahir MN, Saif S, Khan M, Khan ST. COVID-19: A global challenge with old history, epidemiology and progress so far. Molecules 2020;26:39.
https://doi.org/10.3390/molecules26010039
Ndwandwe D, Wiysonge CS. COVID-19 vaccines. Curr Opini Immunol 2021;71:111-6.
https://doi.org/10.1016/j.coi.2021.07.003
Huang YZ, Kuan CC. Vaccination to reduce severe COVID-19 and mortality in COVID-19 patients: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci 2022;26:1770-6.
https://doi.org/10.21203/rs.3.rs-2430314/v1
Kherabi Y, Fiolet T, Rozencwajg S, Salaün JP, PeifferSmadja N. COVID-19 vaccine boosters: What do we know so far? Anaesth Crit Care Pain Med 2021; 40:100959.
https://doi.org/10.1016/j.accpm.2021.100959
Mattiuzzi C, Lippi G. Primary COVID-19 vaccine cycle and booster doses efficacy: analysis of Italian nationwide vaccination campaign. Eur J Public Health 2022;32:328-30.
https://doi.org/10.1093/eurpub/ckab220
Tanriover MD, Akova M. COVID-19 vaccine booster strategy: striving for best practice. Lancet Global Health 2022;10:e774-5.
https://doi.org/10.1016/S2214-109X(22)00204-2
Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y, et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet 2022;399:924-44.
https://doi.org/10.1016/S0140-6736(22)00152-0
Liu Q, Qin C, Liu M, Liu J. Effectiveness and safety of SARS-CoV-2 vaccine in real world studies: a systematic review and meta-analysis. Infect Dis Poverty 2021;10:132.
https://doi.org/10.1186/s40249-021-00915-3
Grewal R, Kitchen SA, Nguyen L, Buchan SA, Wilson SE, Costa AP, et al. Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study. BMJ 2022;378:e071502.
https://doi.org/10.1136/bmj-2022-071502
Abdollahi A, Afsharyzad Y, Vaezi A, Meysamie A. Importance of the COVID-19 vaccine booster dose in protection and immunity. Vaccines (Basel) 2022;10:1708.
https://doi.org/10.3390/vaccines10101708
Abdelmoneim SA, Sallam M, Hafez DM, Elrewany E, Mousli HM, Hammad EM, et al. COVID-19 Vaccine booster dose acceptance: Systematic review and metaanalysis. Trop Med Infect 2022;7:298.
https://doi.org/10.3390/tropicalmed7100298
Sezerol MA, Davun S. COVID-19 Vaccine booster dose acceptance among Older Adults. Vaccines 2023;11:542.
https://doi.org/10.3390/vaccines11030542
Shah A, Coiado OC. COVID-19 vaccine and booster hesitation around the world:A literature review. Front Med (Lausanne) 2023;9:1054557.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Chulalongkorn Medical Journal
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.